JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB199583

Recombinant Human Tau protein

Be the first to review this product! Submit a review

|

(4 Publications)

Recombinant Human Tau protein is a Human Fragment protein, in the 1 to 441 aa range, expressed in Escherichia coli, with >95%, < 1 EU/µg endotoxin level, suitable for SDS-PAGE, HPLC.

View Alternative Names

TAU, MAPT, MSTD, PPND, pTau, DDPAC, MAPTL, MTBT1, MTBT2, Mtapt, Tau-C, FTDP17, RNPTAU, FTDP 17, PHF tau, PHF-tau, 2N3R Tau, 2N4R Tau, AI413597, AW045860, FLJ31424, PPP1R103, MGC134287, MGC138549, MGC156663, TAU_HUMAN, Paired helical filament tau, Paired helical filament-tau, Neurofibrillary tangle protein, Tauopathy and respiratory failure, Microtubule associated protein tau, Microtubule-associated protein tau, Tauopathy and respiratory failure, included, Microtubule associated protein tau isoform 4, Protein phosphatase 1, regulatory subunit 103, G protein beta1/gamma2 subunit interacting factor 1

1 Images
SDS-PAGE - Recombinant Human Tau protein (AB199583)
  • SDS-PAGE

Supplier Data

SDS-PAGE - Recombinant Human Tau protein (AB199583)

SDS-PAGE with ab199583

Key facts

Purity

>95% SDS-PAGE

Endotoxin level

< 1 EU/µg

Expression system

Escherichia coli

Tags

Tag free

Applications

HPLC, SDS-PAGE

applications

Biologically active

No

Accession

P10636

Animal free

No

Carrier free

No

Species

Human

Reconstitution

Reconstitute in PBS, pH 7.4

Storage buffer

pH: 7.4

storage-buffer

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Reactivity", "Dilution Info", "Notes"] }, "values": { "SDS-PAGE": { "reactivity":"TESTED_AND_REACTS", "dilution-info":"", "notes":"<p></p>" }, "HPLC": { "reactivity":"TESTED_AND_REACTS", "dilution-info":"", "notes":"<p></p>" } } }

Sequence info

[{"sequence":"MAEPRQEFEVMEDHAGTYGLGDRKDQGGYTMHQDQEGDTDAGLKESPLQTPTEDGSEEPGSETSDAKSTPTAEDVTAPLVDEGAPGKQAAAQPHTEIPEGTTAEEAGIGDTPSLEDEAAGHVTQARMVSKSKDGTGSDDKKAKGADGKTKIATPRGAAPPGQKGQANATRIPAKTPPAPKTPPSSGEPPKSGDRSGYSSPGSPGTPGSRSRTPSLPTPPTREPKKVAVVRTPPKSPSSAKSRLQTAPVPMPDLKNVKSKIGSTENLKHQPGGGKVQIINKKLDLSNVQSKCGSKDNIKHVPGGGSVQIVYKPVDLSKVTSKCGSLGNIHHKPGGGQVEVKSEKLDFKDRVQSKIGSLDNITHVPGGGNKKIETHKLTFRENAKAKTDHGAEIVYKSPVVSGDTSPRHLSNVSSTGSIDMVDSPQLATLADEVSASLAKQGL","proteinLength":"Fragment","predictedMolecularWeight":"46 kDa","actualMolecularWeight":null,"aminoAcidEnd":441,"aminoAcidStart":1,"nature":"Recombinant","expressionSystem":"Escherichia coli","accessionNumber":"P10636","tags":[]}]

Properties and storage information

Shipped at conditions
Blue Ice
Appropriate short-term storage duration
A few weeks
Appropriate short-term storage conditions
-20°C
Appropriate long-term storage conditions
-20°C
Aliquoting information
Upon delivery aliquot
Storage information
Avoid freeze / thaw cycle
False

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

Tau also known as microtubule-associated protein Tau (MAPT) plays an important role in stabilizing microtubules in neuronal cells. Tau is primarily found in the central nervous system but also exists in peripheral neurons. Human Tau protein comes in six isoforms due to alternative splicing with molecular weights ranging from 48 kDa to 67 kDa. This protein predominantly locates in the axons of neurons where it maintains the stability of microtubule tracks necessary for axonal transport.
Biological function summary

Tau is involved in the assembly and stabilization of microtubules essential for maintaining neuronal structure. It interacts with microtubule-binding domains (MBD) to bind and bundle microtubules facilitating intracellular transport. Tau forms a part of the neuronal cytoskeleton complex working closely with other cytoskeletal proteins to preserve the proper axonal transport and function. Abnormally phosphorylated Tau often termed phospho-Tau disrupts this complex affecting microtubule stability.

Pathways

Tau has critical involvement in several signaling cascades such as the microtubule-binding and transport pathways. Glycogen synthase kinase 3 beta (GSK3β) and cyclin-dependent kinase 5 (CDK5) frequently phosphorylate Tau controlling its interaction with microtubules. Phosphorylated Tau accumulates leading to the formation of neurofibrillary tangles often observed in neurodegenerative conditions. Additionally Tau interacts with GAPDH impacting cellular energy regulation through potential pathway cross-talk involving oxidative stress responses.

Tau is closely associated with Alzheimer's disease and frontotemporal dementia. In Alzheimer's disease hyperphosphorylated Tau aggregates into paired helical filaments forming neurofibrillary tangles while similar aggregates are observed in frontotemporal dementia. In these conditions Tau links to amyloid precursor protein (APP) where misregulated phosphorylation-driven interactions contribute to neurodegeneration. Identifying phospho-Tau and its altered interactions with related proteins aids in understanding and potentially treating these disorders.

Specifications

Form

Lyophilized

Additional notes

Purity greater than 95% as determined by SEC-HPLC and reducing SDS-PAGE.

General info

Function

Promotes microtubule assembly and stability, and might be involved in the establishment and maintenance of neuronal polarity (PubMed : 21985311). The C-terminus binds axonal microtubules while the N-terminus binds neural plasma membrane components, suggesting that tau functions as a linker protein between both (PubMed : 21985311, PubMed : 32961270). Axonal polarity is predetermined by TAU/MAPT localization (in the neuronal cell) in the domain of the cell body defined by the centrosome. The short isoforms allow plasticity of the cytoskeleton whereas the longer isoforms may preferentially play a role in its stabilization.

Post-translational modifications

Phosphorylation at serine and threonine residues in S-P or T-P motifs by proline-directed protein kinases (PDPK1, CDK1, CDK5, GSK3, MAPK) (only 2-3 sites per protein in interphase, seven-fold increase in mitosis, and in the form associated with paired helical filaments (PHF-tau)), and at serine residues in K-X-G-S motifs by MAP/microtubule affinity-regulating kinase (MARK1, MARK2, MARK3 or MARK4), causing detachment from microtubules, and their disassembly (PubMed:23666762, PubMed:7706316). Phosphorylation decreases with age. Phosphorylation within tau/MAP's repeat domain or in flanking regions seems to reduce tau/MAP's interaction with, respectively, microtubules or plasma membrane components (PubMed:7706316). Phosphorylation on Ser-610, Ser-622, Ser-641 and Ser-673 in several isoforms during mitosis. Phosphorylation at Ser-548 by GSK3B reduces ability to bind and stabilize microtubules. Phosphorylation at Ser-579 by BRSK1 and BRSK2 in neurons affects ability to bind microtubules and plays a role in neuron polarization. Phosphorylated at Ser-554, Ser-579, Ser-602, Ser-606 and Ser-669 by PHK. Phosphorylation at Ser-214 by SGK1 mediates microtubule depolymerization and neurite formation in hippocampal neurons. There is a reciprocal down-regulation of phosphorylation and O-GlcNAcylation. Phosphorylation on Ser-717 completely abolishes the O-GlcNAcylation on this site, while phosphorylation on Ser-713 and Ser-721 reduces glycosylation by a factor of 2 and 4 respectively. Phosphorylation on Ser-721 is reduced by about 41.5% by GlcNAcylation on Ser-717. Dephosphorylated at several serine and threonine residues by the serine/threonine phosphatase PPP5C.. Polyubiquitinated. Requires functional TRAF6 and may provoke SQSTM1-dependent degradation by the proteasome (By similarity). PHF-tau can be modified by three different forms of polyubiquitination. 'Lys-48'-linked polyubiquitination is the major form, 'Lys-6'-linked and 'Lys-11'-linked polyubiquitination also occur.. O-glycosylated. O-GlcNAcylation content is around 8.2%. There is reciprocal down-regulation of phosphorylation and O-GlcNAcylation. Phosphorylation on Ser-717 completely abolishes the O-GlcNAcylation on this site, while phosphorylation on Ser-713 and Ser-721 reduces O-GlcNAcylation by a factor of 2 and 4 respectively. O-GlcNAcylation on Ser-717 decreases the phosphorylation on Ser-721 by about 41.5%.. Glycation of PHF-tau, but not normal brain TAU/MAPT. Glycation is a non-enzymatic post-translational modification that involves a covalent linkage between a sugar and an amino group of a protein molecule forming ketoamine. Subsequent oxidation, fragmentation and/or cross-linking of ketoamine leads to the production of advanced glycation endproducts (AGES). Glycation may play a role in stabilizing PHF aggregation leading to tangle formation in AD.

Subcellular localisation

Cytoskeleton

Product protocols

For this product, it's our understanding that no specific protocols are required. You can visit:

Target data

Promotes microtubule assembly and stability, and might be involved in the establishment and maintenance of neuronal polarity (PubMed : 21985311). The C-terminus binds axonal microtubules while the N-terminus binds neural plasma membrane components, suggesting that tau functions as a linker protein between both (PubMed : 21985311, PubMed : 32961270). Axonal polarity is predetermined by TAU/MAPT localization (in the neuronal cell) in the domain of the cell body defined by the centrosome. The short isoforms allow plasticity of the cytoskeleton whereas the longer isoforms may preferentially play a role in its stabilization.
See full target information TAU_HUMAN

Publications (4)

Recent publications for all applications. Explore the full list and refine your search

iScience 27:111165 PubMed39569370

2024

Dual inhibition of aminoacyl-tRNA synthetase interacting multifunctional protein-2 and α-synuclein by steroid derivative is neuroprotective in Parkinson's model.

Applications

Unspecified application

Species

Unspecified reactive species

Jeong-Yong Shin,Min Woo Ha,Ji Hun Kim,Jiwon Cheon,Gum Hwa Lee,Seung-Mann Paek,Yunjong Lee

British journal of anaesthesia 131:726-738 PubMed37537117

2023

Sevoflurane anaesthesia induces cognitive impairment in young mice through sequential tau phosphorylation.

Applications

Unspecified application

Species

Unspecified reactive species

Feng Liang,Mengzhu Li,Miao Xu,Yiying Zhang,Yuanlin Dong,Sulpicio G Soriano,Mary Ellen McCann,Guang Yang,Zhongcong Xie

Molecular neurodegeneration 18:29 PubMed37131250

2023

Mutations in α-synuclein, TDP-43 and tau prolong protein half-life through diminished degradation by lysosomal proteases.

Applications

Unspecified application

Species

Unspecified reactive species

Paul J Sampognaro,Shruti Arya,Giselle M Knudsen,Emma L Gunderson,Angelica Sandoval-Perez,Molly Hodul,Kathryn Bowles,Charles S Craik,Matthew P Jacobson,Aimee W Kao

Alzheimer's research & therapy 10:81 PubMed30115117

2018

IgM response against amyloid-beta in aging: a potential peripheral protective mechanism.

Applications

Unspecified application

Species

Unspecified reactive species

Sudhanshu Agrawal,Edsel M Abud,Shikha Snigdha,Anshu Agrawal
View all publications

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Associated Products

Select an associated product type
Alternative Product
Proteins & Peptides

AB190399

Recombinant Human Tau (mutated N352H) protein

proteins-peptides

recombinant-human-tau-mutated-n352h-protein-ab190399

0

(0 reviews)

Alternative Product
Proteins & Peptides

AB246003

Recombinant human Tau (mutated P301S) protein aggregate (Active)

proteins-peptides

recombinant-human-tau-mutated-p301s-protein-aggregate-active-ab246003

0

(0 reviews)

Alternative Product
Proteins & Peptides

AB246006

Recombinant human Tau protein (Active)

proteins-peptides

recombinant-human-tau-protein-active-ab246006

0

(0 reviews)

Alternative Product
Proteins & Peptides

AB241266

Recombinant Rat Tau protein (His tag)

proteins-peptides

recombinant-rat-tau-protein-his-tag-ab241266

0

(0 reviews)

Alternative Product
Proteins & Peptides

AB242026

Anti-Tau (phospho T181) antibody [EPADXR4] blocking peptide

proteins-peptides

tau-phospho-t181-antibody-epadxr4-blocking-peptide-ab242026

0

(0 reviews)

Alternative Product
Proteins & Peptides

AB19123

Human Tau (phospho S214) peptide

proteins-peptides

human-tau-phospho-s214-peptide-ab19123

0

(0 reviews)

Alternative Product
Proteins & Peptides

AB211410

Anti-Tau antibody - Blocking Peptide

proteins-peptides

tau-antibody-blocking-peptide-ab211410

0

(0 reviews)

Alternative Product
Proteins & Peptides

AB226770

Human Tau (phospho S396) peptide

proteins-peptides

human-tau-phospho-s396-peptide-ab226770

0

(0 reviews)

Alternative Product
Proteins & Peptides

AB246004

Recombinant human Tau (mutated P301L) protein (Active)

proteins-peptides

recombinant-human-tau-mutated-p301l-protein-active-ab246004

0

(0 reviews)

Alternative Product
Proteins & Peptides

AB241263

Recombinant Mouse Tau protein (His tag)

proteins-peptides

recombinant-mouse-tau-protein-his-tag-ab241263

0

(0 reviews)

Alternative Product
Proteins & Peptides

AB242015

Anti-Tau (phospho T231) antibody [EPR2488] Blocking Peptide

proteins-peptides

tau-phospho-t231-antibody-epr2488-blocking-peptide-ab242015

0

(0 reviews)

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com